Celldex Therapeutics, Inc.
CLDX· Nasdaq
Released Aug 4, 2011, during market hours
10-Q filed Aug 4, 2011, 35 days after period end · 0001104659-11-043630
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q2 2011 | Q2 2010 |
|---|---|---|
| Revenue | $1.95M | $2.95M |
| Net Income | -$10.24M | -$9.53M |
| EPS Diluted | -$0.27 | -$0.30 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Celldex Therapeutics, Inc. · CIK 744218 · Engraved from SEC EDGAR
ended Jun 30, 2011 · filed Aug 4, 2011 · 35 d after period end
15.9% from the close of Aug 3, 2011 to the close of Aug 5, 2011, the first after the release.